As previously mentioned, cellular dysmetabolism as a sequela of COVID-19 has been proposed as a potential causative factor of PACS
Amin Sabet, an endocrinologist at UMass Memorial Medical Center
Timing matters, too
Cancer Res 73: 49925002 Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin LX, Ye QH, Jia HL et al (2013) Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes
Tr li: C, vin ung Glutathione 600 cha collagen v cc cht chng oxy ha gip tng cng n hi ca da, gim np nhn v lm da cng mn hn
Anticipated uses: Obesity management (with or without diabetes) Type 2 diabetes Fatty liver disease (potentially pending NASH approval) Retatrutide vs Tirzepatide: Summary Comparison Conclusion Tirzepatide has changed the game in obesity and diabetes carebut retatrutide is poised to redefine the future of metabolic medicine